RELIEF THERAPEUTICS Holding SA

Relief Therapeutics Holding SA is a Swiss, commercial-stage biopharmaceutical company focused on developing and commercializing novel, patent-protected products in selected specialty, rare and ultra-rare diseases. Their current areas of focus are rare dermatologic disorders, rare metabolic disorders, and rare pulmonary diseases. They also leverage their internal research and development capabilities to repurpose existing drugs with proven safety and efficacy.

Relief Therapeutics is a company with a diversified pipeline of assets, including marketed, revenue-generating products and globally patented drug delivery platform technologies. Their mission is to provide therapeutic relief to patients suffering from severe diseases with limited or no alternative treatment options. They are committed to advancing treatment paradigms and delivering improvements in efficacy, safety, and convenience for patients living with select specialty and rare diseases.

Relief Therapeutics is a Swiss, commercial-stage biopharmaceutical company focused on developing and commercializing innovative, patent-protected treatments for select specialty, rare, and ultra-rare diseases. Their mission is to provide therapeutic relief to patients suffering from severe diseases with limited or no alternative treatment options, enabling them to achieve their full potential and live their best lives possible.

Relief Therapeutics promotes a culture that is focused on collaboration and innovation, with a strong emphasis on delivering therapeutic relief to patients suffering from rare diseases. The company values diversity, inclusion, and expertise, fostering a supportive and collaborative environment for its employees. This collaborative culture is reflected in the company's partnerships with contract research organizations, contract manufacturers, licensees, distributors, national clinical networks, and relevant worldwide experts.